α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction

Is Silodosin Different?

Claus Roehrborn, Francisco Cruz, Ferdinando Fusco

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Available α1-blockers (ABs) have different profiles of receptor selectivity. Silodosin exhibits the highest selectivity for the α1A adrenergic receptor. This pharmacological feature couples with a singular urodynamic and clinical profile. The magnitude of bladder outlet obstruction improvement in patients receiving silodosin is higher if compared to other ABs. From a clinical point of view, current evidence suggests an advantage in favor of silodosin in terms of nocturia improvement and cardiovascular safety. The incidence of ejaculatory dysfunction with silodosin is higher compared to other Abs.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalAdvances in Therapy
DOIs
StateAccepted/In press - Oct 17 2016

Fingerprint

Lower Urinary Tract Symptoms
Nocturia
Urinary Bladder Neck Obstruction
Urodynamics
Adrenergic Receptors
Pharmacology
Safety
silodosin
Incidence

Keywords

  • Alpha-blockers
  • Silodosin
  • Urology

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction : Is Silodosin Different? / Roehrborn, Claus; Cruz, Francisco; Fusco, Ferdinando.

In: Advances in Therapy, 17.10.2016, p. 1-12.

Research output: Contribution to journalArticle

@article{f858666c115148c9a91b6d7a9a3c4715,
title = "α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?",
abstract = "Available α1-blockers (ABs) have different profiles of receptor selectivity. Silodosin exhibits the highest selectivity for the α1A adrenergic receptor. This pharmacological feature couples with a singular urodynamic and clinical profile. The magnitude of bladder outlet obstruction improvement in patients receiving silodosin is higher if compared to other ABs. From a clinical point of view, current evidence suggests an advantage in favor of silodosin in terms of nocturia improvement and cardiovascular safety. The incidence of ejaculatory dysfunction with silodosin is higher compared to other Abs.",
keywords = "Alpha-blockers, Silodosin, Urology",
author = "Claus Roehrborn and Francisco Cruz and Ferdinando Fusco",
year = "2016",
month = "10",
day = "17",
doi = "10.1007/s12325-016-0423-5",
language = "English (US)",
pages = "1--12",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",

}

TY - JOUR

T1 - α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction

T2 - Is Silodosin Different?

AU - Roehrborn, Claus

AU - Cruz, Francisco

AU - Fusco, Ferdinando

PY - 2016/10/17

Y1 - 2016/10/17

N2 - Available α1-blockers (ABs) have different profiles of receptor selectivity. Silodosin exhibits the highest selectivity for the α1A adrenergic receptor. This pharmacological feature couples with a singular urodynamic and clinical profile. The magnitude of bladder outlet obstruction improvement in patients receiving silodosin is higher if compared to other ABs. From a clinical point of view, current evidence suggests an advantage in favor of silodosin in terms of nocturia improvement and cardiovascular safety. The incidence of ejaculatory dysfunction with silodosin is higher compared to other Abs.

AB - Available α1-blockers (ABs) have different profiles of receptor selectivity. Silodosin exhibits the highest selectivity for the α1A adrenergic receptor. This pharmacological feature couples with a singular urodynamic and clinical profile. The magnitude of bladder outlet obstruction improvement in patients receiving silodosin is higher if compared to other ABs. From a clinical point of view, current evidence suggests an advantage in favor of silodosin in terms of nocturia improvement and cardiovascular safety. The incidence of ejaculatory dysfunction with silodosin is higher compared to other Abs.

KW - Alpha-blockers

KW - Silodosin

KW - Urology

UR - http://www.scopus.com/inward/record.url?scp=84991669549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991669549&partnerID=8YFLogxK

U2 - 10.1007/s12325-016-0423-5

DO - 10.1007/s12325-016-0423-5

M3 - Article

SP - 1

EP - 12

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

ER -